Literature DB >> 35856125

Diagnostic performance of fluorescence in situ hybridization (FISH) in upper tract urothelial carcinoma (UTUC): a systematic review and meta-analysis.

Amir Hossein Aalami1, Farnoosh Aalami2.   

Abstract

BACKGROUND: Fluorescence in situ hybridization (FISH) is a technique that uses fluorescently labeled DNA probes. Many studies have evaluated the ROC curve (sensitivity and specificity) with the FISH method to diagnose upper tract urothelial carcinoma (UTUC). The current meta-analysis was performed to examine the diagnostic power of the FISH method in UTUC.
METHODS: We reviewed databases and methodically obtained papers for analysis until April 25th, 2022. The Meta-disc V.1.4 and Comprehensive Meta-Analysis V.3.3 software calculated the pooled sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, diagnostic odds ratio, area under the curve (AUC), and summary receiver-operating characteristic (SROC). The I2 and Chi-square tests were used to examine the heterogeneity. Finally, the publication bias was estimated using Begg's and Egger's tests.
RESULTS: A total of 13 articles included 1,067 participants (439 cases and 628 controls). The overall pooled sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), diagnostic odds ratio (DOR), and area under the curve (AUC) were 0.72 (95% CI 0.67-0.76), 0.95 (95% CI 0.93-0.97), 10.42 (95% CI 5.84-18.60), 0.29 (95% CI 0.21-0.40), 38.55 (95% CI 18.58-79.96), and 0.91, respectively. No publication bias was reported based on Begg's and Egger's tests (Begg's p = 0.200; Egger's p = 0.151).
CONCLUSION: This paper clearly shows that the high specificity and acceptable sensitivity of the FISH method make it a promising diagnostic method for UTUC in urine samples. However, further research with higher statistical numbers is needed to strengthen the correlation and be used for diagnostic applications.
© 2022. The Author(s) under exclusive licence to Japan Society of Clinical Oncology.

Entities:  

Keywords:  Biomarker; Cytology; Diagnostic; Fluorescent in situ hybridization (FISH); Meta-analysis; Upper urinary tract urothelial carcinoma (UTUC)

Year:  2022        PMID: 35856125     DOI: 10.1007/s10147-022-02216-7

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.850


  33 in total

Review 1.  European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update.

Authors:  Morgan Rouprêt; Marko Babjuk; Maximilian Burger; Otakar Capoun; Daniel Cohen; Eva M Compérat; Nigel C Cowan; Jose L Dominguez-Escrig; Paolo Gontero; A Hugh Mostafid; Joan Palou; Benoit Peyronnet; Thomas Seisen; Viktor Soukup; Richard J Sylvester; Bas W G van Rhijn; Richard Zigeuner; Shahrokh F Shariat
Journal:  Eur Urol       Date:  2020-06-24       Impact factor: 20.096

2.  Prognostic significance of fluorescent in situ hybridisation in the follow-up of non-muscle-invasive bladder cancer.

Authors:  Massimo Maffezzini; Fabio Campodonico; Giacomo Capponi; Giorgio Canepa; Stefania Casazza; Roberto Bandelloni; Stefania Tamagno; Matteo Puntoni
Journal:  Anticancer Res       Date:  2010-11       Impact factor: 2.480

Review 3.  The impact of lymphovascular invasion in patients treated with radical nephroureterectomy for upper tract urothelial carcinoma: An extensive updated systematic review and meta-analysis.

Authors:  Judith Stangl-Kremser; Gianluca Muto; Antonio Andrea Grosso; Alberto Briganti; Eva Comperat; Fabrizio Di Maida; Rodolfo Montironi; Mesut Remzi; Benjamin Pradere; Francesco Soria; Simone Albisinni; Morgan Roupret; Shahrokh Francois Shariat; Andrea Minervini; Jeremy Yuen-Chun Teoh; Marco Moschini; Alessia Cimadamore; Andrea Mari
Journal:  Urol Oncol       Date:  2022-02-28       Impact factor: 3.498

4.  Universal Lynch Syndrome Screening Should be Performed in All Upper Tract Urothelial Carcinomas.

Authors:  Jennifer Y Ju; Anne M Mills; Mani S Mahadevan; Jinbo Fan; Stephen H Culp; Martha H Thomas; Helen P Cathro
Journal:  Am J Surg Pathol       Date:  2018-11       Impact factor: 6.394

Review 5.  Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC).

Authors:  Francesco Soria; Shahrokh F Shariat; Seth P Lerner; Hans-Martin Fritsche; Michael Rink; Wassim Kassouf; Philippe E Spiess; Yair Lotan; Dingwei Ye; Mario I Fernández; Eiji Kikuchi; Daher C Chade; Marko Babjuk; Arthur P Grollman; George N Thalmann
Journal:  World J Urol       Date:  2016-09-07       Impact factor: 4.226

Review 6.  Fluorescence in situ hybridization in diagnostic cytology.

Authors:  Kevin C Halling; Benjamin R Kipp
Journal:  Hum Pathol       Date:  2007-08       Impact factor: 3.466

7.  Genome oligopaint via local denaturation fluorescence in situ hybridization.

Authors:  Yanbo Wang; Wayne Taylor Cottle; Haobo Wang; Xinyu Ashlee Feng; John Mallon; Momcilo Gavrilov; Scott Bailey; Taekjip Ha
Journal:  Mol Cell       Date:  2021-03-02       Impact factor: 17.970

8.  The complex relationship between upper urinary tract and bladder cancer: clinical and predictive issues.

Authors:  Francesca Sanguedolce; Luigi Cormio
Journal:  Transl Androl Urol       Date:  2018-05

Review 9.  Optimal Management of Upper Tract Urothelial Carcinoma: Current Perspectives.

Authors:  Jeffrey J Leow; Zhenbang Liu; Teck Wei Tan; Yee Mun Lee; Eu Kiang Yeo; Yew-Lam Chong
Journal:  Onco Targets Ther       Date:  2020-01-06       Impact factor: 4.147

10.  Neoadjuvant and Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma: A 2020 Systematic Review and Meta-analysis, and Future Perspectives on Systemic Therapy.

Authors:  Jeffrey J Leow; Yew Lam Chong; Steven L Chang; Begoña P Valderrama; Thomas Powles; Joaquim Bellmunt
Journal:  Eur Urol       Date:  2020-08-12       Impact factor: 20.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.